Transforming Hypertrophic Cardiomyopathy Care
The Clinical Trial Manager at Braveheart Bio will oversee regional study management for a global Phase 3 program, focusing on site selection, start‑up, maintenance, and close‑out activities across Europe and vendor coordination. The role involves close collaboration with CROs, internal stakeholders, and junior team members to ensure study execution stays on track.
Advancing treatments to improve outcomes and quality of life for patients with hypertrophic cardiomyopathy and related heart conditions.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Transforming Hypertrophic Cardiomyopathy Care.
9% above the average for this role
Sr. Clinical Trial Manager
Structure Therapeutics
Clinical Trial Manager
Acrivon Therapeutics
Senior Clinical Trial Manager
Peptilogics
Clinical Trial Manager/ Sr. Clinical Trial Manager
City Therapeutics
Clinical Trial Manager/Sr Clinical Trial Manager
Jobgether
Clinical Trial Manager (CTM or Sr. CTM)
Acrivon Therapeutics